Conventus Orthopaedics said it closed a Series AA round worth $24 million it plans to use to commercialize 1of its self-expanding extremities implants and advance R&D on another.
Venture Capital/Private Equity
The importance of being scrappy: Tips from med tech entrepreneur Amar Sawhney
Polaris Partners raises $450m for new healthcare fund
Venture capital investment in medtech grows in Q3
Venture capitalists put more cash into more deals for medical device companies during the 3rd quarter, according to a report from PricewaterhouseCoopers.
Medical device companies pulled down $586 million in 78 deals during the 3rd quarter, up 13% in dollars and 18% in deal volume compared with Q3 2013.
Sources: Philips attracts private equity bids for lighting unit
Dr. Tom Fogarty: Venture capital is dead and it’s starting to stink
In the 50 years since Dr. Tom Fogarty invented the catheter-based treatment for blood clots that’s now the standard of care, he’s founded more than 30 medical device startups, placing him among the most prolific inventors in the biomedical space.
Forgarty is also, without a doubt, the industry’s best quote.
SV Life Sciences buys majority stake in Ximedica
Ximedica said today that SV Life Sciences picked up a majority interest in the Providence, R.I.-based medical device development company from co-founders Stephen Lane and Aidan Petrie for an undisclosed amount.
ZipLine Medical adds $5.7m to Series C round
ZipLine Medical said it added a $5.7 million extension to its $4.3 million Series C round, with new investor China Materialia promising to help the company expand sales in the People’s Republic.
Sinopsys Surgical sniffs up $8.3m for sinusitis device
Stealth-mode startup Sinopsys Surgical said it raised $8.3 million in an equity funding round for the technique it’s developing to repurpose the tear duct to drain into the sinuses as a way to relieve chronic sinusitis.
CEO Dr. Harry Ross was a partner with Aweida Venture Partners of Superior, Colo., near to Sinopsys Surgical’s Boulder headquarters.